The Canadian Biosimilars Forum welcomes the Quebec government’s intention to accelerate the uptake of biosimilars
The Canadian Biosimilars Forum welcomes the Quebec government's intention to move towards biosimilars. This is a pivotal step in improving the care of patients who will be transitioning from a reference biologic to a biosimilar in a safe, effective and controlled manner.
COVID-19 has demonstrated the need for rapid investment in the health care system, hence the importance of such an initiative to achieve significant savings to support the health care system and promote innovation. The savings generated by biosimilars can be reinvested in the public drug plan, improved patient care and health care infrastructure, while helping to ensure that Quebec patients have rapid access to innovative drugs in the future. They can also be used to support the province's world-class life sciences sector.
The Canadian Biosimilars Forum offers its full cooperation in implementing a transition to biosimilars across Quebec in the patients’ best interest.
Additional Resources
From the Government of Quebec: